Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of oral solithromycin for otorhinolaryngological infections
jRCT2080223412Phase 3
- Sponsor
- Fujifilm
- Start
- Dec 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of solithromycin in otolaryngological infection, sponsored by Fujifilm.
02
Drugs
solithromycin
03
Conditions
otolaryngological infection
Beyond the preview
Go deeper on jRCT2080223412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223412.